Management of the metabolic effects of HIV and HIV drugs

被引：50
作者：
Brown, Todd T. [1 ]
Glesby, Marshall J. [2 ]
机构：
[1] Johns Hopkins Univ, Div Endocrinol & Metab, Baltimore, MD 21287 USA
[2] Weill Cornell Med Coll, Div Infect Dis, New York, NY 10021 USA
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2012年 / 8卷 / 01期
关键词：
HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HORMONE-RELEASING-FACTOR; PLACEBO-CONTROLLED TRIAL; REVERSE-TRANSCRIPTASE INHIBITORS; MYOCARDIAL-INFARCTION RATES; ABDOMINAL FAT ACCUMULATION; REGIONAL ADIPOSE-TISSUE; LIPID-LOWERING THERAPY; HUMAN GROWTH-HORMONE;
D O I：
10.1038/nrendo.2011.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Morphologic and metabolic abnormalities, including subcutaneous adipose tissue wasting, central adipose tissue accumulation, dyslipidemia and disorders of glucose metabolism are common among HIV-infected patients receiving highly active antiretroviral therapy (HAART) and contribute to the risk of cardiovascular disease in this population. The pathogenesis of these disorders is due to complicated interactions between effects of chronic HIV infection, HAART medications and patient factors, including genetic susceptibility. HAART has transformed HIV into a chronic condition for many patients and as a result the majority of HIV-infected patients in many areas of the developed world will soon be aged >= 50 years. Given that metabolic and cardiovascular diseases increase with aging, knowledge of the optimal management of these conditions is essential for practitioners caring for HIV-infected patients, including endocrine subspecialists. This Review highlights the clinical management of these disorders, focusing on the latest evidence regarding the efficacy of treatment strategies, newly available medications and potential interactions between HAART medications and medications used to treat metabolic disorders.
引用
收藏
页码：11 / 21
页数：11
相关论文
共 167 条
[1]   A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087 [J].
Aberg, JA ;
Zackin, RA ;
Brobst, SW ;
Evans, SR ;
Alston, BL ;
Henry, WK ;
Glesby, MJ ;
Torriani, FJ ;
Yang, YJ ;
Owens, SI ;
Fichtenbaum, CJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (09) :757-767
[2]   Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].
Adams, M ;
Montague, CT ;
Prins, JB ;
Holder, JC ;
Smith, SA ;
Sanders, L ;
Digby, JE ;
Sewter, CP ;
Lazar, MA ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153
[3]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[4]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[5]   Relationship between HAART adherence and adipose tissue alterations [J].
Ammassari, A ;
Antinori, A ;
Cozzi-Lepri, A ;
Trotta, MP ;
Nasti, G ;
Ridolfo, AL ;
Mazzotta, F ;
Wu, AW ;
D'Arminio Monforte, A ;
Galli, M .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S140-S144
[6]   Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].
Arioglu, E ;
Duncan-Morin, J ;
Sebring, N ;
Rother, KI ;
Gottlieb, N ;
Lieberman, J ;
Herion, D ;
Kleiner, DE ;
Reynolds, J ;
Premkumar, A ;
Sumner, AE ;
Hoofnagle, J ;
Reitman, ML ;
Taylor, SI .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274
[7]   Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial [J].
Aslangul, Elisabeth ;
Assoumou, Jambert ;
Bittar, Randa ;
Valantin, Marc-Antoine ;
Kalmykova, Olga ;
Peytavin, Gilles ;
Fievet, Marie-Helene ;
Boccara, Franck ;
Bonnefont-Rousselot, Dominique ;
Melchior, Jean-Claude ;
Giral, Philippe ;
Costagliola, Dominique .
AIDS, 2010, 24 (01) :77-83
[8]   High-Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection [J].
Baker, Jason ;
Ayenew, Woubeshet ;
Quick, Harrison ;
Hullsiek, Katherine Huppler ;
Tracy, Russell ;
Henry, Keith ;
Duprez, Daniel ;
Neaton, James D. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (02) :285-292
[9]  
Bastard JP, 2009, ANTIVIR THER, V14, pA5
[10]   Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity [J].
Bhasin, Shalender ;
Parker, Robert A. ;
Sattler, Fred ;
Haubrich, Richard ;
Alston, Beverly ;
Umbleja, Triin ;
Shikuma, Cecilia M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) :1049-1057
12345678910